Literature DB >> 25442495

The highly prevalent H3F3A mutation in giant cell tumours of bone is not shared by sporadic central giant cell lesion of the jaws.

Carolina Cavaliéri Gomes1, Marina Gonçalves Diniz2, Fabrício Rezende Amaral2, Bruna Viana Antonini Guimarães1, Ricardo Santiago Gomez3.   

Abstract

OBJECTIVE: Central giant cell lesion (CGCL) and giant cell tumour (GCT) are bone lesions that share similar microscopic features. Recently, it was reported that 90% of bone GCT exhibit either p.Gly34 Trp or p.Gly34 Leu in H3F3A, one of two genes for histone H3.3 located on chromosome 1. We aimed to test whether sporadic CGCL of the jaws share the H3F3A mutations reported in GCT of other bones.
METHODS: Nine samples of CGCL of the jaws were included in the study, and mutations were assessed by direct sequencing.
RESULTS: None of the CGCL samples presented the recurrent p.Gly34 Trp or p.Gly34 Leu mutations in the H3F3A gene.
CONCLUSION: On the basis of our findings, H3F3A p.Gly34 Trp or p.Gly34 Leu mutations are not a frequent event in CGCL. If these alterations are confirmed to be exclusive of GCT, the assessment of H3F3A mutations may help in the differential diagnosis of GCT and CGCL of the jaws.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25442495     DOI: 10.1016/j.oooo.2014.07.011

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  12 in total

1.  Giant cell tumor of soft tissue is genetically distinct from its bone counterpart.

Authors:  Jen-Chieh Lee; Cher-Wei Liang; Christopher Dm Fletcher
Journal:  Mod Pathol       Date:  2017-01-13       Impact factor: 7.842

Review 2.  Giant Cell Tumor of the Larynx Treated by Surgery and Adjuvant Denosumab: Case Report and Review of the Literature.

Authors:  Aaron E Yancoskie; Douglas K Frank; John E Fantasia; Steven Savona; Nicole Eiseler; Ilan Reder; Leonard B Kahn
Journal:  Head Neck Pathol       Date:  2015-03-08

3.  Neurofibromatosis Type 1 With Cherubism-like Phenotype, Multiple Osteolytic Bone Lesions of Lower Extremities, and Alagille-syndrome: Case Report With Literature Survey.

Authors:  Reinhard E Friedrich; Jozef Zustin; Andreas M Luebke; Thorsten Rosenbaum; Martin Gosau; Christian Hagel; Felix K Kohlrusch; Ilse Wieland; Martin Zenker
Journal:  In Vivo       Date:  2021 May-Jun       Impact factor: 2.155

4.  A Comprehensive Understanding of the Genomic Bone Tumor Landscape: A Multicenter Prospective Study.

Authors:  Xianbiao Xie; Yiying Bian; Haomiao Li; Junqiang Yin; Lantian Tian; Renbing Jiang; Ziliang Zeng; Xiaoliang Shi; Zixiong Lei; Changhe Hou; Yueting Qu; Liwei Wang; Jingnan Shen
Journal:  Front Oncol       Date:  2022-06-08       Impact factor: 5.738

Review 5.  Cone-beam computed tomographic imaging of central giant cell granuloma: A comprehensive review.

Authors:  Mehrnaz Tahmasbi-Arashlow; Paras B Patel; Madhu K Nair; Hui Liang; Yi-Shing Lisa Cheng
Journal:  Imaging Sci Dent       Date:  2022-04-28

6.  Immune Surveillance Plays a Role in Locally Aggressive Giant Cell Lesions of Bone.

Authors:  Ahmad Al-Sukaini; Francis J Hornicek; Zachary S Peacock; Leonard B Kaban; Soldano Ferrone; Joseph H Schwab
Journal:  Clin Orthop Relat Res       Date:  2017-07-19       Impact factor: 4.176

7.  Symplastic/pseudoanaplastic giant cell tumor of the bone.

Authors:  Judy Sarungbam; Narasimhan Agaram; Sinchun Hwang; Chao Lu; Lu Wang; John Healey; Meera Hameed
Journal:  Skeletal Radiol       Date:  2016-03-28       Impact factor: 2.199

8.  H3F3A G34 mutation DNA sequencing and G34W immunohistochemistry analysis in 366 cases of giant cell tumors of bone and other bone tumors.

Authors:  Lihua Gong; Marilyn M Bui; Wen Zhang; Xiaoqi Sun; Ming Zhang; Ding Yi
Journal:  Histol Histopathol       Date:  2020-09-04       Impact factor: 2.303

Review 9.  Insight into the pathogenesis and nature of Central Giant Cell Lesions of the Jaws.

Authors:  Paul-Charles Edwards
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2015-03-01

10.  H3F3A (Histone 3.3) G34W Immunohistochemistry: A Reliable Marker Defining Benign and Malignant Giant Cell Tumor of Bone.

Authors:  Fernanda Amary; Fitim Berisha; Hongtao Ye; Manu Gupta; Alice Gutteridge; Daniel Baumhoer; Rebecca Gibbons; Roberto Tirabosco; Paul O'Donnell; Adrienne M Flanagan
Journal:  Am J Surg Pathol       Date:  2017-08       Impact factor: 6.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.